Celsius (NASDAQ:CELH) Price Target Raised to $50.00

Celsius (NASDAQ:CELH) had its price objective raised by Truist Financial from $45.00 to $50.00 in a research report sent to investors on Friday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock.

CELH has been the topic of several other reports. JPMorgan Chase & Co. raised their target price on Celsius from $39.00 to $44.00 and gave the company an “overweight” rating in a report on Friday, May 2nd. UBS Group raised their target price on Celsius from $43.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, April 17th. LADENBURG THALM/SH SH dropped their target price on Celsius from $62.00 to $58.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Wells Fargo & Company lifted their price objective on Celsius from $44.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, June 4th. Finally, Stifel Nicolaus dropped their price objective on Celsius from $45.00 to $37.00 and set a “buy” rating on the stock in a report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $47.22.

Celsius Stock Performance

Shares of NASDAQ:CELH opened at $40.60 on Friday. The company has a market cap of $10.46 billion, a P/E ratio of 92.27, a PEG ratio of 2.90 and a beta of 1.43. Celsius has a one year low of $21.10 and a one year high of $71.00. The business’s 50-day simple moving average is $36.80 and its 200 day simple moving average is $30.86.

Celsius (NASDAQ:CELH) last announced its earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million for the quarter, compared to analysts’ expectations of $349.09 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. The business’s quarterly revenue was down 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.27 earnings per share. Analysts predict that Celsius will post 0.89 earnings per share for the current year.

Insider Activity

In related news, Director Joyce Russell sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the transaction, the director now owns 19,106 shares in the company, valued at $543,947.82. The trade was a 17.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 2.55% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Alliancebernstein L.P. boosted its position in Celsius by 26.3% during the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after purchasing an additional 3,753,055 shares during the period. Vanguard Group Inc. boosted its position in Celsius by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company’s stock valued at $416,517,000 after purchasing an additional 345,837 shares during the period. Alyeska Investment Group L.P. boosted its position in Celsius by 60.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock valued at $181,164,000 after purchasing an additional 2,591,345 shares during the period. FMR LLC boosted its position in Celsius by 64.2% during the 4th quarter. FMR LLC now owns 4,055,148 shares of the company’s stock valued at $106,813,000 after purchasing an additional 1,585,839 shares during the period. Finally, Champlain Investment Partners LLC acquired a new position in Celsius during the 4th quarter worth $85,068,000. Institutional investors and hedge funds own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.